U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. FDA Technology Transfer Program
  4. Licensing and Collaboration Opportunities
  5. Listeria Monocytogene Strains Containing Antibiotic Resistance and Green-Flourescent Protein Markers
  1. Licensing and Collaboration Opportunities

Listeria Monocytogene Strains Containing Antibiotic Resistance and Green-Flourescent Protein Markers

Download the Abstract (PDF-138KB)

 

Technology Summary

Listeria monocytogenes (Lm) is a foodborne bacterial pathogen that is the causative agent of listeriosis in humans and animals. Lm illness is oftenlimited in healthy individuals but virulent Lm strains can cause serious illness, including death, amongst immunocompromised individuals.

To aid in the research and detection of Lm, investigators at the FDA developed Lm control strains using the three major disease-causing serotypes, 1/2a, 1/2b, and 4b. The strains were identified by their antibiotic resistance and a green fluorescent protein (GFP) tag was introduced to allow confirmation and separation of the control strains from the background flora.

These strains can potentially be used for Lm research and product development around detection and routine analysis of food, clinical, and environmental samples.

Potential Commercial Applications Competitive Advantages
  • Research tool to study Lm
  • Use in the development of diagnostics for detection and analysis of Lm
  • Natural occurring strains with antibiotic-resistance and GFP tag

Development Stage: Research Materials

Inventors:

  • Atin Datta
  • Surasri Sahu
  • Laurel Burall

Publications:

  • Sahu, NS., et. al. Growth potential of Listeria monocytogenes in artificially contaminate celery and chicken salad. Food Control 73 (2017) 1229-1236. Here

Product Area:  listeria, monocytogenes, pathogen, celery, contaminant, chicken, vaccine development

FDA Reference No: E-2017-020

Licensing Contact:
FDA Technology Transfer Program
Email: FDAInventionlicensing@fda.hhs.gov

Back to Top